Precision medicine has gotten its fair share of hype.
But for those diagnosed with cancer, actually getting that kind of care — specifically tailored diagnosis and treatment based on a patient's molecular profile — is still fairly challenging.
“You can’t just call up a lab and say, ‘I want precision medicine,’” said Chip Petricoin, a George Mason University professor and chief scientific officer of McLean-based precision medicine company Perthera Inc.
Now his 28-employee company…
Precision medicine has gotten its fair share of hype.
But for those diagnosed with cancer, actually getting that kind of care — specifically tailored diagnosis and treatment based on a patient's molecular profile — is still fairly challenging.
“You can’t just call up a lab and say, ‘I want precision medicine,’” said Chip Petricoin, a George Mason University professor and chief scientific officer of McLean-based precision medicine company Perthera Inc.
Now his 28-employee company…
